Modeling Alzheimer's disease in transgenic mice: effect of age and of Presenilin1 on amyloid biochemistry and pathology in APP/London mice

By Dewachter I.   van Dorpe J.   Spittaels K.   Tesseur I.   Van Den Haute C.   Moechars D.   Van Leuven F.  

Experimental Gerontology, Vol. 35, Iss. 6, 2000-09 ,pp. : 831-841

Elsevier

Access to resources Recommend Favorite

Neurohormonal Signaling Pathways and the Regulation of Alzheimer -Amyloid Precursor Metabolism

By Gandy S.  

Trends in Endocrinology and Metabolism, Vol. 10, Iss. 7, 1999-09 ,pp. : 273-279

Elsevier

Access to resources Recommend Favorite

Cerebrospinal Fluid Levels of Amyloid Precursor Protein and Amyloid β-Peptide in Alzheimer’s Disease and Major Depression – Inverse Correlation with Dementia Severity

By  

European Neurology, Vol. 39, Iss. 2, 1998-02 ,pp. : 111-118

Karger

Access to resources Recommend Favorite

Reduced Expression of Amyloid Precursor Protein, Presenilin-1 and rab3a in Cortical Brain Regions in Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 12, Iss. 4, 2001-05 ,pp. : 243-250

Karger

Access to resources Recommend Favorite

The Effect of Simvastatin Treatment on the Amyloid Precursor Protein and Brain Cholesterol Metabolism in Patients with Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 19, Iss. 5-6, 2005-04 ,pp. : 256-265

Karger

Access to resources Recommend Favorite